WHO says monkeypox not a health emergency, but leaders ‘deeply concerned’

The UN agency convened a meeting last week to discuss the outbreak
The World Health Organization has determined that monkeypox is not yet a global health emergency after a meeting of international experts last week.
The health body said in a statement that although there were some differing views within the committee, they ultimately agreed by consensus that the outbreak does not warrant the Public Health Emergency of International Concern (PHEIC) title.
However, WHO Director-General Tedros Adhanom Ghebreyesus noted that the situation remains serious. He said: ‘I am deeply concerned about the monkeypox outbreak, this is clearly an evolving health threat that my colleagues and I in the WHO Secretariat are following extremely closely.’
The ‘global emergency’ label currently only applies to the coronavirus pandemic and efforts to eradicate polio.
There have been more than 3,200 confirmed cases of monkeypox and one death reported in the last six weeks from 48 countries where it does not usually spread, according to according to the UN agency. Almost 1,500 cases and 70 deaths in central Africa, where the disease is more common, have also been reported, with the majority in the Democratic Republic of Congo.
The disease spreads through close contact and symptoms include fever, rashes and lesions on the skin. It has been spreading largely between men who have sex with men outside the countries where it is endemic, though it is not defined as a sexually transmitted infection.
There are vaccines and treatments available for monkeypox, although they are in limited supply. On June 14, vaccine maker Bavarian Nordic announced that it had signed a supply agreement with the European Union for 110,000 doses of its Imvanex shot. These will be made available to EU Member States, Norway and Iceland.
There are no current plans for widespread vaccination. Countries with available doses, such as the UK and Germany, have recommended the shot for those at the highest risk of contracting the disease, which includes gay and bisexual men, healthcare workers, and close contacts.
Related News
-
News US FDA adds haemodialysis bloodlines to devices shortage list
On March 14, 2025, the US FDA published an open letter to healthcare providers citing continuing supply disruptions of haemodialysis bloodlines, an essential component of dialysis machines. -
News Women in Pharma: Manufacturing personal and team success
Our monthly Women in Pharma series highlights the influential lives and works of impactful women working across the pharmaceutical industry, and how the industry can work towards making the healthcare industry and workplace more equitable and inclusive... -
News Pfizer may shift production back to US under Trump pharma tariffs
At the 45th TD Cowen annual healthcare conference in Boston, USA, Pfizer CEO Albert Bourla outlined the potential for Pfizer to shift its overseas drug manufacturing back to the US as pharmaceutical industry players weigh their options against Presiden... -
News Experimental drug for managing aortic valve stenosis shows promise
The new small molecule drug ataciguat is garnering attention for its potential to manage aortic valve stenosis, which may prevent the need for surgery and significantly improve patient experience. -
News Women in Pharma: Connecting accessible pharma packaging to patients – a Pharmapack Special
Throughout our Women in Pharma series, we aim to highlight how CPHI events encourage discussions around diversity, equity, and inclusion initiatives in the pharmaceutical industry. -
News Vertex Pharmaceuticals stock jumps as FDA approves non-opioid painkiller
UK-based Vertex Pharmaceuticals saw their stock shares soar as the US FDA signed off on the non-opioid painkiller Journavx, also known as suzetrigine, for patients with moderate to severe acute pain, caused by surgery, accidents, or injuries. -
News Trump administration halts global supply of HIV, malaria, tuberculosis drugs
In various memos circulated to the United States Agency for International Development (USAID), the Trump administration has demanded contractors and partners to immediately stop work in supplying lifesaving drugs for HIV, malaria, and tuberculosis to c... -
News 2024 Drug Approvals: a lexicon of notable drugs and clinical trials
50 drugs received FDA approval in 2024. The centre for biologics evaluation and research also identified six new Orphan drug approvals as under Biologics License Applications (BLAs). The following list picks out key approvals from the list, and highlig...
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance